TNYA (STOCKS)
Tenaya Therapeutics, Inc. Common Stock
$0.720000
+0.008200 (+1.15%)
Prev close: $0.711800
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Faraz Ali
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $156.81M
- Employees
- 97
- P/E (TTM)
- -1.52
- P/B (TTM)
- 1.45
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
9
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.09 | $-0.09 | -0.0011 | -1.24% |
|
Dec 2025 (Q4)
|
$-0.12 | $-0.12 | +0.0037 | +2.99% |
|
Sep 2025 (Q3)
|
$-0.12 | $-0.15 | +0.0307 | +20.37% |
|
Jun 2025 (Q2)
|
$-0.14 | $-0.26 | +0.1150 | +45.10% |
Financial Statements
| Revenues | $225.00K |
| Nonoperating Income/Loss | $2.85M |
| Operating Expenses | $86.08M |
| Depreciation and Amortization | $7.60M |
| Research and Development | $62.37M |
| Other Operating Expenses | $16.11M |
| Operating Income/Loss | -$85.86M |
| Income/Loss From Continuing Operations After Tax | -$83.01M |
| Income/Loss From Continuing Operations Before Tax | -$83.01M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$83.01M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$83.01M |
| Net Income/Loss Available To Common Stockholders, Basic | -$83.01M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.46 |
| Diluted Earnings Per Share | -$0.46 |
| Basic Average Shares | 550,460,479 |
| Diluted Average Shares | 550,460,479 |
| Assets | $135.07M |
| Current Assets | $96.56M |
| Cash | $80.90M |
| Prepaid Expenses | $5.02M |
| Other Current Assets | $10.64M |
| Noncurrent Assets | $38.51M |
| Fixed Assets | $25.96M |
| Other Non-current Assets | $12.55M |
| Liabilities | $28.88M |
| Current Liabilities | $16.78M |
| Accounts Payable | $1.91M |
| Other Current Liabilities | $14.87M |
| Noncurrent Liabilities | $12.10M |
| Equity | $106.19M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $106.19M |
| Liabilities And Equity | $135.07M |
| Net Cash Flow From Operating Activities | -$64.39M |
| Net Cash Flow From Operating Activities, Continuing | -$64.39M |
| Net Cash Flow From Investing Activities | $33.77M |
| Net Cash Flow From Investing Activities, Continuing | $33.77M |
| Net Cash Flow From Financing Activities | $57.73M |
| Net Cash Flow From Financing Activities, Continuing | $57.73M |
| Net Cash Flow | $27.12M |
| Net Cash Flow, Continuing | $27.12M |
| Comprehensive Income/Loss | -$83.00M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$83.00M |
| Other Comprehensive Income/Loss | $10.00K |